Patent details
EP1126822
Title:
CONTROLLED RELEASE LIQUID DELIVERY COMPOSITIONS WITH LOW INITIAL DRUG BURST
Basic Information
- Publication number:
- EP1126822
- PCT Application Number:
- PCT/US/1999/025444
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP999567795
- PCT Publication Number:
- WO/2000/024374
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CONTROLLED RELEASE LIQUID DELIVERY COMPOSITIONS WITH LOW INITIAL DRUG BURST
- French Title of Invention:
- COMPOSITIONS DE DISTRIBUTION LIQUIDES A LIBERATION CONTROLEE AVEC FAIBLE DECHARGE INITIALE DE MEDICAMENT
- German Title of Invention:
- FLÜSSIGE ZUSAMMENSETZUNGEN MIT KONTROLLIERTER FREIGABE MIT NIEDRIGEM INITIALFREISETZUNGSSTOSS DES WIRKSTOFFS
- SPC Number:
-
Dates
- Filing date:
- 28/10/1999
- Grant date:
- 11/02/2004
- EP Publication Date:
- 11/02/2004
- PCT Publication Date:
- 04/05/2000
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 29/08/2001
- EP B1 Publication Date:
- 11/02/2004
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 28/10/2018
- Expiration date:
- 28/10/2019
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/12/2017
-
-
- Name:
- Tolmar Therapeutics, Inc.
- Address:
- 2579 Midpoint Drive, Fort Collins, CO 80525, United States (US)
History of Owners
- From:
- 14/12/2017
- To:
- 14/12/2017
- Name:
- QLT USA, Inc.
- Address:
- 2579 Midpoint Drive, Fort Collins, CO 80525, United States (US)
- From:
- 28/10/1999
- To:
- 14/12/2017
- Name:
- ATRIX LABORATORIES INC.
- Address:
- 2579 Midpoint Drive, Fort Collins, Colorado 80525, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 11/02/2004
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- ZHOU Mingxing
- Address:
- United States (US)
2
- Name:
- JARR Eileen M.
- Address:
- United States (US)
3
- Name:
- DUNN Richard, L.
- Address:
- United States (US)
4
- Name:
- CHANDRASHEKAR Bhagya, L.
- Address:
- United States (US)
Priority
- Priority Number:
- 181355
- Priority Date:
- 28/10/1998
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
A61K 9/00;
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2018/02
- Publication date:
- 15/01/2018
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
2
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2018/02
- Publication date:
- 15/01/2018
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20170000455A
- Date Registered:
- 14/12/2017
- Licence Effective Date:
-
- Licence Expiration Date:
-
- Scope of Licence:
-
- Deed Filer:
-
MARKS & CLERK LLP
- Journal Edition Number:
-
- Text:
-
- Country Code:
-
- Updated Licence Number:
-
- Terminated Licence Number:
-
Added Owner(s)
- Name:
- QLT USA, Inc.
- Address:
- 2579 Midpoint Drive, Fort Collins, CO 80525, United States (US)
Removed Pledgee
- Name:
-
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name/address
- Deed Number:
- RC20170000455B
- Date Registered:
- 14/12/2017
- Licence Effective Date:
-
- Licence Expiration Date:
-
- Scope of Licence:
-
- Deed Filer:
-
MARKS & CLERK LLP
- Journal Edition Number:
-
- Text:
-
- Country Code:
-
- Updated Licence Number:
-
- Terminated Licence Number:
-
Added Owner(s)
- Name:
- Tolmar Therapeutics, Inc.
- Address:
- 2579 Midpoint Drive, Fort Collins, CO 80525, United States (US)
Removed Pledgee
- Name:
-
- Address:
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 09/10/2017
- Last Annual Fee Paid Number:
- 19
- Last Annual Fee Paid Amount:
- 281 Euro
- Payer:
- MARKS & CLERK LLP